| mRNA |
BRD-K09587429 |
CTRPv2 |
pan-cancer |
AAC |
0.38 |
2e-22 |
| mRNA |
BRD8899 |
CTRPv2 |
pan-cancer |
AAC |
0.36 |
8e-22 |
| mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
-0.28 |
1e-15 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.29 |
2e-15 |
| mRNA |
BRD-K52037352 |
CTRPv2 |
pan-cancer |
AAC |
0.3 |
1e-13 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
8e-13 |
| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
2e-12 |
| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
6e-12 |
| mRNA |
PD-0325901 |
GDSC1000 |
pan-cancer |
AAC |
-0.24 |
8e-12 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
2e-11 |